0000805928-22-000067.txt : 20220603
0000805928-22-000067.hdr.sgml : 20220603
20220603161405
ACCESSION NUMBER: 0000805928-22-000067
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220601
FILED AS OF DATE: 20220603
DATE AS OF CHANGE: 20220603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JOHNSON JOHN
CENTRAL INDEX KEY: 0001410781
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36046
FILM NUMBER: 22994534
MAIL ADDRESS:
STREET 1: DENDREON CORPORATION
STREET 2: 1301 2ND AVENUE
CITY: SEATTLE
STATE: WA
ZIP: 98101
FORMER NAME:
FORMER CONFORMED NAME: Johnson John H
DATE OF NAME CHANGE: 20070827
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axogen, Inc.
CENTRAL INDEX KEY: 0000805928
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 411301878
STATE OF INCORPORATION: MN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
BUSINESS PHONE: (386) 462-6817
MAIL ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
FORMER COMPANY:
FORMER CONFORMED NAME: AxoGen, Inc.
DATE OF NAME CHANGE: 20111004
FORMER COMPANY:
FORMER CONFORMED NAME: LECTEC CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
wf-form4_165428722800361.xml
FORM 4
X0306
4
2022-06-01
0
0000805928
Axogen, Inc.
AXGN
0001410781
JOHNSON JOHN
13631 PROGRESS BOULEVARD, SUITE 400
ALACHUA
FL
32615
1
0
0
0
Employee Stock Option (right to purchase)
9.29
2022-06-01
4
A
0
11811
0
A
2032-06-01
Common Stock
11811.0
11811
D
Restricted Stock Units
2022-06-01
4
A
0
6459
0
A
Common Stock
6459.0
6459
D
Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.
Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
John Johnson
2022-06-03